Grangeville Health & Rehabilitation Center Medicare and Medicaid Location: 410 East North Second Street, Grangeville, Idaho 83530 Ratings: Phone: (208) 983-1131 |
News Archive
Increasing evidence shows that physical activity and exercise training may delay or prevent the onset of Alzheimer's disease (AD). In aging humans, aerobic exercise training increases gray and white matter volume, enhances blood flow, and improves memory function.
Mice that vocalize in a repetitive, halting pattern similar to human stuttering may provide insight into a condition that has perplexed scientists for centuries, according to a new study by researchers at Washington University School of Medicine in St. Louis and the National Institutes of Health.
Neuralstem, Inc. announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.
The Boston Globe reports on Dr. Martin Samuels, a Harvard Medical School neurologist, who started "a new company that he says will provide continuing medical education to doctors across the country — without funding from the pharmaceutical industry.
› Verified 1 days ago